Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed Aug 13, 2021. Long positions only.
- Positions
- 136
- No 13F data for Q4 2020
- Portfolio value
- $7.52B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Deerfield Healthcare Tech Ac244413100 | COM CL A | 20,000 | $242.0K | <0.1% | – | – | – |
| SANASana Biotechnology, Inc. | COM | 10,000 | $335.0K | <0.1% | – | – | History |
| CVMCel Sci Corp | COM PAR NEW | 33,700 | $513.0K | <0.1% | – | – | History |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 133,066 | $573.0K | <0.1% | – | – | – |
| PHVSPharvaris N.V. | COM | 27,000 | $755.0K | <0.1% | – | – | History |
| SC Health CorpG78516401 | *W EXP 99/99/999 | 500,000 | $945.0K | <0.1% | – | – | – |
| SRRASierra Oncology, Inc. | COM NEW | 66,655 | $1.15M | <0.1% | – | – | History |
| Vincerx Pharma, Inc.92731L114 | *W EXP 12/24/202 | 300,000 | $1.21M | <0.1% | – | – | – |
| EIGREiger BioPharmaceuticals, Inc. | COM | 139,890 | $1.24M | <0.1% | – | – | History |
| RACEFerrari N.V. | COM | 6,200 | $1.30M | <0.1% | – | – | History |
| Butterfly Network, Inc.124155110 | *W EXP 05/27/202 | 233,333 | $1.50M | <0.1% | – | – | – |
| CM Life Sciences Inc18978W109 | COM CL A | 127,000 | $1.89M | <0.1% | – | – | – |
| PLXPPLx Pharma Winddown Corp. | COM | 222,180 | $2.01M | <0.1% | – | – | History |
| MOTSMotus GI Holdings, Inc. | COM | 1,800,542 | $2.07M | <0.1% | – | – | History |
| GRTXGalera Therapeutics, Inc. | COM | 254,664 | $2.25M | <0.1% | – | – | History |
| RGNXREGENXBIO Inc. | COM | 69,283 | $2.36M | <0.1% | – | – | History |
| SGTXSigilon Therapeutics, Inc. | COM | 125,000 | $2.79M | <0.1% | – | – | History |
| SNCEScience 37 Holdings, Inc. | COM | 300,000 | $3.04M | <0.1% | – | – | History |
| TLISTalis Biomedical Corp | COM | 250,000 | $3.21M | <0.1% | – | – | History |
| VRAYViewRay, Inc. | COM | 751,748 | $3.27M | <0.1% | – | – | History |
| MRUSMerus N.V. | COM | 175,000 | $3.65M | <0.1% | – | – | History |
| TXMDTherapeuticsMD, Inc. | COM | 2,750,000 | $3.69M | <0.1% | – | – | History |
| Deerfield Healthcare Tech Ac244413209 | UNIT 07/16/2025 | 300,000 | $3.93M | 0.1% | – | – | – |
| Consonance HFW Acquisition CG2445M129 | UNIT 99/99/9999 | 500,000 | $4.88M | 0.1% | – | – | – |
| Longview Acquisition Corp. II54319Q204 | UNIT 99/99/9999 | 500,000 | $5.02M | 0.1% | – | – | – |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 450,000 | $5.04M | 0.1% | – | – | History |
| PHRPhreesia, Inc. | COM | 100,000 | $5.21M | 0.1% | – | – | History |
| BCTG Acquisition Corp05492W103 | COM | 500,000 | $5.56M | 0.1% | – | – | – |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 1,933,551 | $5.59M | 0.1% | – | – | – |
| VINCVincerx Pharma, Inc. | COM NEW | 300,000 | $5.79M | 0.1% | – | – | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 270,000 | $6.04M | 0.1% | – | – | History |
| AMWLAmerican Well Corp | CL A | 355,000 | $6.17M | 0.1% | – | – | History |
| DRIODarioHealth Corp. | COM NEW | 327,869 | $6.31M | 0.1% | – | – | History |
| TARAProtara Therapeutics, Inc. | COM STK | 421,642 | $6.64M | 0.1% | – | – | History |
| TCRRTCR2 Therapeutics Inc. | COM | 313,300 | $6.92M | 0.1% | – | – | History |
| PSTXPoseida Therapeutics, Inc. | COM | 787,745 | $7.52M | 0.1% | – | – | History |
| XENEXenon Pharmaceuticals Inc. | COM | 515,042 | $9.22M | 0.1% | – | – | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 470,440 | $9.55M | 0.1% | – | – | History |
| RACBResearch Alliance Corp. II | COM CL A | 1,000,000 | $10.3M | 0.1% | – | – | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 311,673 | $10.3M | 0.1% | – | – | History |
| CLOVClover Health Investments, Corp. | COM CL A | 1,500,000 | $10.3M | 0.1% | – | – | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 1,000,000 | $10.6M | 0.1% | – | – | – |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,150,641 | $10.7M | 0.1% | – | – | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 755,375 | $12.5M | 0.2% | – | – | – |
| VTRSViatris Inc | Stock | 1,004,419 | $14.0M | 0.2% | – | – | History |
| ADPTAdaptive Biotechnologies Corp | COM | 352,804 | $14.2M | 0.2% | – | – | History |
| HYPRHyperfine, Inc. | CL A SHS | 1,500,000 | $14.9M | 0.2% | – | – | History |
| ACCDAccolade, Inc. | COM | 345,741 | $15.7M | 0.2% | – | – | History |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 1,500,000 | $15.8M | 0.2% | – | – | – |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,059,800 | $15.9M | 0.2% | – | – | History |
| CM Life Sciences II Inc125842203 | UNIT 02/25/2028 | 1,250,000 | $16.0M | 0.2% | – | – | – |
| CYPHCypherpunk Technologies Inc. | COM | 8,476,496 | $16.1M | 0.2% | – | – | History |
| ACRSAclaris Therapeutics, Inc. | COM | 650,000 | $16.4M | 0.2% | – | – | History |
| NEPTFNeptune Wellness Solutions Inc. | COM | 12,849,706 | $16.6M | 0.2% | – | – | History |
| CTMXCytomX Therapeutics, Inc. | COM | 2,153,974 | $16.6M | 0.2% | – | – | History |
| PCVXVaxcyte, Inc. | COM | 850,000 | $16.8M | 0.2% | – | – | History |
| IMCRImmunocore Holdings plc | ADS | 400,000 | $17.0M | 0.2% | – | – | History |
| SILKSilk Road Medical Inc | COM | 340,100 | $17.2M | 0.2% | – | – | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 444,878 | $19.3M | 0.3% | – | – | History |
| KRROKorro Bio, Inc. | COM | 2,113,661 | $20.1M | 0.3% | – | – | History |
| MREOMereo BioPharma Group plc | SPON ADS | 6,000,000 | $20.2M | 0.3% | – | – | History |
| ONEM1Life Healthcare Inc | COM | 519,844 | $20.3M | 0.3% | – | – | History |
| DRNADicerna Pharmaceuticals Inc | COM | 800,000 | $20.5M | 0.3% | – | – | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,950,167 | $20.9M | 0.3% | – | – | History |
| COLLCollegium Pharmaceutical, Inc | COM | 978,277 | $23.2M | 0.3% | – | – | History |
| FBRXForte Biosciences, Inc. | COM | 685,000 | $23.5M | 0.3% | – | – | History |
| HCATHealth Catalyst, Inc. | COM | 506,084 | $23.7M | 0.3% | – | – | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,099,028 | $24.0M | 0.3% | – | – | – |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,888,889 | $24.2M | 0.3% | – | – | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 746,557 | $24.6M | 0.3% | – | – | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 1,800,180 | $25.5M | 0.3% | – | – | History |
| STOKStoke Therapeutics, Inc. | COM | 671,978 | $26.1M | 0.3% | – | – | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 409,341 | $27.1M | 0.4% | – | – | History |
| ONCROncorus, Inc. | COM | 1,989,987 | $27.7M | 0.4% | – | – | History |
| COGTCogent Biosciences, Inc. | COM | 3,188,750 | $28.0M | 0.4% | – | – | History |
| IMTXImmatics N.V. | SHS | 2,500,000 | $28.0M | 0.4% | – | – | History |
| ISEEIVERIC bio, Inc. | COM | 4,585,512 | $28.3M | 0.4% | – | – | History |
| NUVBNuvation Bio Inc. | COM CL A | 3,041,004 | $29.0M | 0.4% | – | – | History |
| ADMAAdma Biologics, Inc. | COM | 16,584,802 | $29.2M | 0.4% | – | – | History |
| UTHRUnited Therapeutics Corp | COM | 175,000 | $29.3M | 0.4% | – | – | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 797,404 | $29.4M | 0.4% | – | – | History |
| PRVBProvention Bio, Inc. | COM | 2,852,058 | $29.9M | 0.4% | – | – | History |
| AGRXAgile Therapeutics Inc | COM | 15,919,925 | $33.1M | 0.4% | – | – | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,250,000 | $35.0M | 0.5% | – | – | History |
| ACADAcadia Pharmaceuticals Inc | COM | 1,410,305 | $36.4M | 0.5% | – | – | History |
| LYRALyra Therapeutics, Inc. | COM | 3,222,560 | $37.3M | 0.5% | – | – | History |
| BEAMBeam Therapeutics Inc. | COM | 537,635 | $37.8M | 0.5% | – | – | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 575,007 | $39.9M | 0.5% | – | – | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,143,790 | $40.4M | 0.5% | – | – | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,695,505 | $41.0M | 0.5% | – | – | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $41.1M | 0.5% | – | – | History |
| KODKodiak Sciences Inc. | COM | 389,008 | $44.1M | 0.6% | – | – | History |
| YARWYarrow Bioscience, Inc. | COM | 6,773,954 | $46.4M | 0.6% | – | – | History |
| EXASExact Sciences Corp | COM | 353,523 | $46.6M | 0.6% | – | – | History |
| VERUVeru Inc. | COM | 4,451,342 | $48.0M | 0.6% | – | – | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,659,381 | $51.6M | 0.7% | – | – | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 3,610,412 | $54.7M | 0.7% | – | – | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,477,481 | $55.0M | 0.7% | – | – | History |
| RXDXPrometheus Biosciences, Inc. | COM | 3,314,032 | $55.4M | 0.7% | – | – | History |
| ATNXAthenex, Inc. | COM | 13,532,467 | $57.3M | 0.8% | – | – | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.